CRB
Chad R. Baker Portfolio holdings
AUM
$538M
This Quarter Return
+12.36%
1 Year Return
+20.8%
3 Year Return
+87.18%
5 Year Return
+140.51%
10 Year Return
–
AUM
$444M
AUM Growth
+$444M
(+12%)
Cap. Flow
+$5.97M
Cap. Flow
% of AUM
1.34%
Top 10 Holdings %
Top 10 Hldgs %
45.48%
Holding
57
New
4
Increased
10
Reduced
16
Closed
4
Top Buys
| 1 |
Cloudflare
NET
|
$5.29M |
| 2 |
Veralto
VLTO
|
$3.84M |
| 3 |
CRISPR Therapeutics
CRSP
|
$2.91M |
| 4 |
TJX Companies
TJX
|
$1.87M |
| 5 |
Alcon
ALC
|
$1.58M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$3.25M |
| 2 |
International Flavors & Fragrances
IFF
|
$2.19M |
| 3 |
Apple
AAPL
|
$1.97M |
| 4 |
Illumina
ILMN
|
$1.76M |
| 5 |
3M
MMM
|
$1.5M |
Sector Composition
| 1 | Technology | 33.05% |
| 2 | Industrials | 18.33% |
| 3 | Healthcare | 17.81% |
| 4 | Consumer Discretionary | 12.98% |
| 5 | Communication Services | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
New York Times
NYT
$9.55B
| $7.02M | 1.58% |
143,325
+6,000
| +4% | +$294K |
|
27
Lowe's Companies
LOW
$145B
| $6.25M | 1.41% |
28,100
| – | – |
|
|
28
CRISPR Therapeutics
CRSP
$4.76B
| $6.17M | 1.39% |
98,520
+46,420
| +89% | +$2.91M |
|
29
Home Depot
HD
$405B
| $6.09M | 1.37% |
17,565
+125
| +0.7% | +$43.3K |
|
|
30
TJX Companies
TJX
$154B
| $5.81M | 1.31% |
61,930
+19,930
| +47% | +$1.87M |
|
31
Stryker
SYK
$148B
| $5.73M | 1.29% |
19,145
| – | – |
|
32
Walmart
WMT
$777B
| $5.41M | 1.22% |
34,340
+1,225
| +4% | +$193K |
|
33
Adobe
ADBE
$146B
| $5.37M | 1.21% |
9,000
| – | – |
|
34
Zoetis
ZTS
$67.2B
| $4.9M | 1.1% |
24,818
| – | – |
|
35
Colgate-Palmolive
CL
$68B
| $4.08M | 0.92% |
51,200
| – | – |
|
|
36
Veralto
VLTO
$26B
| $3.84M | 0.86% |
+46,690
| New | +$3.84M |
|
37
CSX Corp
CSX
$59.8B
| $3.54M | 0.8% |
102,000
| – | – |
|
38
RTX Corp
RTX
$212B
| $3.23M | 0.73% |
38,348
| – | – |
|
|
39
Alphabet (Google) Class C
GOOG
$2.53T
| $3.11M | 0.7% |
22,090
-23,040
| -51% | -$3.25M |
|
|
WIRE
40
DELISTED
Encore Wire Corp
WIRE
| $2.78M | 0.62% |
13,000
| – | – |
|
41
Merck
MRK
$212B
| $2.37M | 0.53% |
21,700
| – | – |
|
42
Cigna
CI
$80.4B
| $1.75M | 0.39% |
5,841
| – | – |
|
43
Canadian National Railway
CNI
$60.1B
| $1.67M | 0.38% |
13,300
-80
| -0.6% | -$10.1K |
|
44
Exxon Mobil
XOM
$489B
| $1.64M | 0.37% |
16,400
| – | – |
|
|
45
Alcon
ALC
$38.6B
| $1.58M | 0.36% |
+20,265
| New | +$1.58M |
|
46
Fortive
FTV
$15.8B
| $1.1M | 0.25% |
15,000
| – | – |
|
47
Pfizer
PFE
$141B
| $705K | 0.16% |
24,500
| – | – |
|
48
NVIDIA
NVDA
$4.12T
| $567K | 0.13% |
1,145
-205
| -15% | -$102K |
|
49
Novo Nordisk
NVO
$249B
| $557K | 0.13% |
5,380
-250
| -4% | -$25.9K |
|
50
Aptiv
APTV
$17B
| $538K | 0.12% |
+5,995
| New | +$538K |
|